Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Janz, Martin Dr. (6) Kieback, Elisa Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (8) Rajewsky, Nikolaus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (5) Uckert, Wolfgang Prof. Dr. (2) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (17) (-) Daniel, Peter Prof. Dr. (1) (-) Biologie maligner Lymphome (1) (-) Molekulare Immunologie und Gentherapie (17) Translationale Onkologie solider Tumore (2) 1992 (4) 1993 (7) (-) 1994 (5) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (2) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (4) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 18 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 1994199620062008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein 01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni 01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein 01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman 01. Januar 1996 / Gene Ther Cancer vaccines in gene therapy T. Blankenstein Z. Qin Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni
01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman